Promus Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$169K Hold
221
0.11% 84
2025
Q2
$172K Sell
221
-216
-49% -$168K 0.11% 82
2025
Q1
$361K Hold
437
0.27% 57
2024
Q4
$337K Buy
+437
New +$362K 0.26% 57

Other funds holding LLY

Promus Capital's LLY Position: Q3 2025 in Review

Promus Capital held its Eli Lilly (LLY) position steady in Q3 2025 at 221 shares worth $169K. The position accounts for 0.11% of the portfolio, ranked #84.

Promus Capital first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $361K in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Promus Capital held 221 shares of Eli Lilly worth $169K as of Q3 2025.
  • Promus Capital left its Eli Lilly share count unchanged in Q3 2025.
  • Eli Lilly made up 0.11% of Promus Capital's portfolio in Q3 2025, its #84 holding.
  • Promus Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • Promus Capital's Eli Lilly position peaked at $361K in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.